北京市婴儿母亲和孕妇对呼吸道合胞病毒认知现状及相关因素分析
结果显示RSV知晓率47.30%,知识评分中位数为0分,健康信念平均65.92分,使用愿意率43.51%;家庭收入、RSV知识和健康信念水平与使用意愿相关。
要点
- 北京市婴儿母亲和孕妇RSV知晓率47.30%,知识评分中位数为0分,认知水平较低。
- RSV预防生物制品使用愿意率为43.51%,健康信念平均得分65.92分。
- 家庭人均月收入2万以上、RSV知识高于中位数、健康信念高于平均分者使用意愿更高。
核心结论
- 北京市婴儿母亲和孕妇对RSV认知、对RSV预防生物制品的健康信念水平和使用意愿均较低。
- 家庭收入、RSV认知和RSV预防生物制品的健康信念水平与RSV预防生物制品的使用意愿相关。
研究设计与样本
- 采用横断面研究设计,以北京市全部23家RSV感染防控试点医疗机构为研究现场。
- 于2024年9月招募前往研究现场就诊的孕妇,以及调查期间符合RSV预防生物制品适用范围的婴儿母亲为研究对象。
- 通过问卷调查收集一般人口学特征、RSV认知、健康信念水平和使用意愿与需求等信息。
主要发现
- RSV知晓率47.30%,RSV知识评分M(Q1,Q3)为0(0,60)分。
- 健康信念水平总得分(65.92±15.38)分,为其婴儿使用RSV预防制品的愿意率43.51%。
- 与家庭人均月收入<1万元者相比,家庭人均月收入2万以上者使用意愿OR=1.529(95%CI:1.069~2.188)。
- 与RSV知识评分低于中位数者相比,RSV知识高于中位数者使用意愿OR=1.005(95%CI:1.001~1.009)。
- 与健康信念评分低于平均分者相比,健康信念评分高于平均分者使用意愿OR=1.090(95%CI:1.078~1.102),P<0.05。
关键数值与推荐
- 研究对象最希望获得RSV相关知识的渠道依次为医务工作者(67.43%)、新闻客户端(57.77%)和社区组织(56.15%)。
- 最需要了解的信息为RSV感染预防措施(79.93%)、RSV预防生物制品适用人群与禁忌(77.36%)。
- 最希望获得RSV预防生物制品服务的场所为预防接种门诊(85.54%)。
临床怎么用
- 应通过医务工作者、新闻客户端和社区组织等渠道加强RSV相关知识的健康教育。
- 重点向婴儿母亲和孕妇普及RSV感染预防措施及预防生物制品的适用人群与禁忌。
- 可考虑在预防接种门诊提供RSV预防生物制品服务,以提高可及性和使用意愿。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To analyze the current status and related factors of understanding of respiratory syncytial virus (RSV) among mothers of infants and pregnant women in Beijing City. Methods: Using a cross-sectional study design, all 23 RSV infection prevention and control pilot medical institutions in Beijing were selected as the research sites. Pregnant women who visited the research sites for medical treatment in September 2024, as well as mothers of infants who met the eligibility criteria for RSV prevention biological products during the survey period (October 1, 2023, to September 30, 2024), were recruited as the research participants. Collect information on the general demographic characteristics, awareness of RSV, health belief levels about RSV prevention biological products, and willingness and demand for their use through a questionnaire survey. The multivariate logistic regression model was used to analyze the factors of willingness to use RSV prevention biological products. Results: A total of 1 480 research participants were included, with the awareness rate of RSV 47.30% and a median RSV knowledge score (Q1, Q3) of 0 (0, 60) points. The overall average score of health belief to RSV prevention biological products was (65.92±15.38) points and 43.51% of participants expressed willingness to use it for their infants. The multivariate logistic regression model showed that compared with those with a per capita monthly income less than 10 000 yuan, a knowledge score on RSV below the median, and a health belief score below the mean for RSV prevention biological products, the participants with a per capita monthly income of 20 000 yuan or more (OR=1.529, 95%CI:1.069-2.188), the awareness of RSV above the median (OR=1.005, 95%CI:1.001-1.009), and a health belief score above the mean (OR=1.090, 95%CI:1.078-1.102) were more willing to use RSV prevention biological products (P<0.05). The first three channels which the participants most desired to RSV-related knowledge were medical workers (67.43%), news clients (57.77%), and community organizations (56.15%); the information they most needed to understand was prevention measures for RSV infection (79.93%) and the applicable population and contraindications of RSV prevention biological products (77.36%); and the place they most desired to obtain RSV prevention biological product services was in vaccination clinics (85.54%). Conclusion: The awareness of RSV among mothers of infants and pregnant women in Beijing, as well as their health belief levels and willingness to use RSV prevention biological products, is all relatively low. Family income, awareness of RSV, and health belief levels regarding RSV prevention biological products are correlated with the willingness to use these products. 目的: 分析北京市婴儿母亲和孕妇对呼吸道合胞病毒(RSV)的认知现况及相关因素。 方法: 采用横断面研究设计,以当前北京市全部23家RSV感染防控试点医疗机构为研究现场,于2024年9月招募前往研究现场就诊的孕妇,以及调查期间符合RSV预防生物制品适用范围(2023年10月1日至2024年9月30日)婴儿的母亲为研究对象。通过问卷调查收集一般人口学特征、对RSV的认知、对RSV预防生物制品的健康信念水平和使用意愿与需求等信息;采用多因素logistic回归模型分析使用意愿的相关因素。 结果: 共纳入1 480名研究对象,RSV知晓率47.30%,RSV知识评分M(Q1,Q3)为0(0,60)分;健康信念水平总得分(65.92±15.38)分;为其婴儿使用RSV预防制品的愿意率43.51%。多因素logistic回归模型分析结果显示,与家庭人均月收入<1万元、RSV知识评分低于中位数、对RSV预防生物制品健康信念评分低于平均分者相比,家庭人均月收入2万以上(OR=1.529,95%CI:1.069~2.188)、RSV知识高于中位数(OR=1.005,95%CI:1.001~1.009)和健康信念评分高于平均分(OR=1.090,95%CI:1.078~1.102)的研究对象更有意愿使用RSV预防生物制品。研究对象最希望获得RSV相关知识的渠道依次为医务工作者、新闻客户端和社区组织等(分别占67.43%、57.77%和56.15%);最需要了解的信息为RSV感染预防措施(79.93%)、RSV预防生物制品适用人群与禁忌(77.36%);最希望获得RSV预防生物制品服务的场所为预防接种门诊(85.54%)。 结论: 北京市婴儿母亲和孕妇对RSV认知、对RSV预防生物制品的健康信念水平和使用意愿均较低;家庭收入、RSV认知和RSV预防生物制品的健康信念水平与RSV预防生物制品的使用意愿相关。.
引用
- Gao P, Ji YX, Tan YF, et al. [Cognitive status and related factors of understanding of respiratory syncytial virus infection among mothers of infants and pregnant women in Beijing City]. Zhonghua Yu Fang Yi Xue Za Zhi. 2026. PMID: 41856629. doi:10.3760/cma.j.cn112150-20250324-00233
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。